FDA Drug recall D-0400-2025
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Wi…
- FDA Drug
- Class II
- ongoing
- Published 2025-05-07
On 2025-05-07 the FDA classified a Class II recall of Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Wi… by Mckesson Medical Surgical Corporate Office, citing severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0400-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-04-25 |
| Published | 2025-05-07 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Mckesson Medical Surgical Corporate Office |
| Distribution | FL, MS |
Product
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
Reason
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Identifiers
| code_info | Lot #: 1MP24042, Exp 6/30/26 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Other recalls by Mckesson Medical Surgical Corporate Office
- Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived
FDA Device · Class II · 2025-08-27 · Mckesson Medical Surgical Corporate Office - PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513…
FDA Drug · Class II · 2025-07-30 · Mckesson Medical Surgical Corporate Office - BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK
FDA Drug · Class II · 2025-07-30 · Mckesson Medical Surgical Corporate Office - EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 9…
FDA Drug · Class II · 2025-07-30 · Mckesson Medical Surgical Corporate Office - BD MICROBIOLOGY FLUID THIOGLYCOLLATE MED TUBE 1004321196 (100/CT) MEDIA
FDA Device · Class II · 2025-06-04 · Mckesson Medical Surgical Corporate Office
All Mckesson Medical Surgical Corporate Office recalls
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0400-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.